UC

Hyundai Executive Receives Two Awards for Community Leadership

Retrieved on: 
Tuesday, October 17, 2023
Hyundai Motor Company, National Hispanic Heritage Month (United States), Progress in Human Geography, UC Irvine Institute of Transportation Studies, Human, Northgate, UC, Hyundai Motor America, MIDI mockup, Humanity, University of California, Irvine, Conference, Organization, Paul Merage School of Business, Multimedia, UCI, SUV, Social responsibility, Hyundai Motor Manufacturing Alabama, Business, Orange County, Nursing, Automotive industry, Hyundai

FOUNTAIN VALLEY, Calif., Oct. 17, 2023 /PRNewswire/ -- Brandon Ramirez, director, corporate social responsibility and external relations, was recognized with multiple awards for his community leadership.

Key Points: 
  • FOUNTAIN VALLEY, Calif., Oct. 17, 2023 /PRNewswire/ -- Brandon Ramirez, director, corporate social responsibility and external relations, was recognized with multiple awards for his community leadership.
  • "I'm proud to support the Latino community and local communities at large both inside and outside the walls of Hyundai."
  • Community Action Partnership of Orange County, a long-time partner of Hyundai Motor America, received a $2,000 grant on behalf of Ramirez and Hyundai.
  • He is the executive sponsor of Hyundai's "Amigos Unidos" employee resource group, which is tasked with community engagement and raising cultural awareness at Hyundai.

New fertility research could save time during treatment cycles for those undergoing IUIs

Retrieved on: 
Tuesday, October 17, 2023
Fertility, Artificial insemination, UC, Pregnancy Outcome Prediction study, Physician, Congress, SIS, Research, SGF, Reproductive medicine, Patient, IUI, UC Davis Medical Center, Birth control, Medical device

ROCKVILLE, Md., Oct. 17, 2023 /PRNewswire/ -- New research from Shady Grove Fertility (SGF), a US Fertility practice, assures fertility patients who have undergone a saline-infused sonogram (SIS) that they can proceed with intrauterine insemination (IUI) in the same cycle and expect comparable pregnancy rates as if they had waited for another cycle.

Key Points: 
  • "As one of the only private practice fertility centers in the nation to employ a full-time dedicated research team, our top priority is conducting research that makes a difference in the lives and treatment plans of our patients," shares Phillip A. Romanski, M.D., M.Sc.
  • , fertility specialist at SGF New York and SGF Research Director.
  • "This new study can provide data for our patients that can help them move forward with fertility treatment more quickly in their IUI cycles.
  • We know that fertility treatment is a time commitment, and we can now feel confident about giving time back to our patients with an evidence-based method."

Rise8 Unveils Agenda and Coalition Partners for Prodacity 2023, Featuring Talks from GovTech Innovators and Change Agents with the Audacity to Continuously Ship Outcomes to Prod

Retrieved on: 
Tuesday, October 17, 2023
Omni, Dark, Government, AWS, UC, University of California, Berkeley, Author, United States Marine Corps, Red Hat, Future, Hamilton Hotel (Washington, D.C.), Amazon Web Services, United States Air Force, Hamilton Hotel, Government Technology Agency, Partnership, United States Department of Veterans Affairs, Ernest K. Warburton (US Air Force), Site reliability engineering, Software, RET, Acceleration, DevOps, Mobile phone, Planview, Wiz, Skylight, Mobilize, Veteran, United States Army, Metronome

WASHINGTON, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Rise8 , delivering elite software development for critical missions, today announced the final agenda for Prodacity 2023, its second annual symposium.

Key Points: 
  • WASHINGTON, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Rise8 , delivering elite software development for critical missions, today announced the final agenda for Prodacity 2023, its second annual symposium.
  • Prodacity is the only in-person symposium for GovTech innovators and change agents, both newcomers and veterans alike, with a purpose to set a baseline for how to do DevOps in government and achieve mission outcomes.
  • Where: This Prodacity 2023 symposium will take place in-person, at the Hamilton Hotel in Washington, D.C.
    Why: Attendees will experience a sales-free, no-theater, master-class style event designed to help them learn how to initiate and scale govtech transformation.
  • Who: The list of speakers features govtech innovators and enterprise change agents with the audacity to continuously ship outcomes to production.

Res Nova Biologics Recruits Abortion Pill Reversal Founder to Scientific Advisory Board

Retrieved on: 
Tuesday, October 17, 2023
Science, Women, Biotechnology, Research, Pharmaceutical, Oncology, Health, Consumer, Neoplasm, Multimedia, Progesterone, UC, Reproductive medicine, Biology, Breast cancer, ST, Coronavirus Scientific Advisory Board, Pregnancy, Immunotherapy, Santa Monica, California, Growth, Translation, University of California, Davis, TSOI, Pharmaceutical industry, Birth control, Medical imaging

View the full release here: https://www.businesswire.com/news/home/20231017959162/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231017959162/en/
    Dr. Delgado is an expert in the biology of pregnancy and the abortion pill, being the founder of “Abortion Pill Reversal” and having been the first to publish in the peer-reviewed literature successful reversal of mifepristone administration using progesterone treatment1.
  • Res Nova is developing FloraStilbene™, a proprietary formulation of RU-486 and pterostilbene which has been shown to overcome tumor associated immune suppression2 and increases responsiveness to chemotherapy and immunotherapy3.
  • “The similarities between pregnancy and oncology, including angiogenesis, immune modulation, and rapid growth are striking,” said Dr. George Delgado.
  • “In my opinion the concept of leveraging the effects of the abortion pill in life-saving as opposed to a life-taking scenario is extremely exciting.

WSJ Ranks CSUN No. 2 Public University in California

Retrieved on: 
Tuesday, October 17, 2023
California State University, Social work, Learning, The Wall Street Journal, University of California, Berkeley, Social mobility, Workforce, Engineering, Northridge, UC, Student, CSUN, WSJ, Nursing

NORTHRIDGE, Calif., Oct. 17, 2023 /PRNewswire/ -- California State University, Northridge (CSUN) is honored to announce our recognition as the No.

Key Points: 
  • NORTHRIDGE, Calif., Oct. 17, 2023 /PRNewswire/ -- California State University, Northridge (CSUN) is honored to announce our recognition as the No.
  • 2 public university in California and No.
  • Thanks to this new metric, CSUN also ranked the nation's fifth-best university for social mobility and twentieth for student experience.
  • And impressively, among California public universities, CSUN is second only to UC Berkley – and above all other CSUs.

Yosemite's Beverly Lu, Ph.D. joins Ten63's Board of Directors

Retrieved on: 
Tuesday, October 17, 2023
Partnership, UC, Amgen, University of California, Berkeley, Therapy, Emerson Collective, General partnership, Harvard University, Cancer, McKinsey & Company, Chemistry, Drug discovery, Patient, Medical device, California Institute of Technology, Yosemite National Park

Prior to launch, the Yosemite team co-led Ten63's oversubscribed Series A financing with Hatteras Venture Partners.

Key Points: 
  • Prior to launch, the Yosemite team co-led Ten63's oversubscribed Series A financing with Hatteras Venture Partners.
  • Led by Reed Jobs, Yosemite is focused on making cancer non-lethal within our lifetime.
  • In connection with the partnership, Yosemite's Dr. Beverly Lu joined the company's board of directors.
  • Dr. Lu serves on Ten63's board directors along with Dr. Frenkel, Clay Thorp, General Partner of Hatteras Venture Partners, Damien Petty, operating partner at Morpheus Ventures, and Dr. Steve Hall formerly from Lilly Ventures.

Snom Americas™ Embraces Visionary Leadership with Marc Magliano as Vice President, Channel Business for the Americas

Retrieved on: 
Wednesday, October 11, 2023
IP, INTERNET, UC, Software as a service, Communication, Enterprise, Environment, Growth, Marketing, DECT, OEM, Zoom, Voice over IP, Telecommunications, Sales, Management, Telco, SDWAN

TIGARD, Ore., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Snom Americas™, renowned for pioneering advanced business communication solutions, has appointed Marc Magliano as the Vice President, Channel Business for the Americas. The appointment marks a seminal stride towards fostering robust channel and telecoms reseller relationships, ensuring innovation remains at the forefront of Snom’s agenda.

Key Points: 
  • TIGARD, Ore., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Snom Americas™, renowned for pioneering advanced business communication solutions, has appointed Marc Magliano as the Vice President, Channel Business for the Americas.
  • The appointment marks a seminal stride towards fostering robust channel and telecoms reseller relationships, ensuring innovation remains at the forefront of Snom’s agenda.
  • Boasting an illustrious three-decade career in channel sales and distribution channel leadership, Marc Magliano is no stranger to crafting robust channel strategies.
  • His appointment comes in alignment with Snom's unwavering commitment to revitalizing its channel strategy and nurturing strategic collaborations that underpin mutual growth and success.

Ventyx Biosciences Announces Positive Results from the Phase 2 Trial of VTX002 in Patients with Moderate-to-Severely Active Ulcerative Colitis

Retrieved on: 
Monday, October 9, 2023
Mount Sinai, UC, Mayo, Week, Safety, Atrioventricular block, Ulcerative colitis, Webcast, Macular edema, SAN, Bradycardia, Gastroenterology, Fungal infection, Inflammation, Icahn School of Medicine at Mount Sinai, Patient, Pharmaceutical industry, Medical imaging, Phosphorus, Medicine

SAN DIEGO, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced positive results from the Phase 2 trial of VTX002, a novel oral S1P1 receptor modulator, in patients with moderate-to-severely active ulcerative colitis (UC).

Key Points: 
  • The Phase 2 trial of VTX002 was a 13-week, randomized, double-blind, placebo-controlled, dose-ranging trial evaluating the efficacy and safety of two oral doses of VTX002 (30 mg and 60 mg once daily) in patients with moderate-to-severely active UC.
  • The primary endpoint was the proportion of patients achieving clinical remission at Week 13 as defined by the modified Mayo Clinic Score.
  • I am excited to see the positive results from the VTX002 Phase 2 trial.” Dr. Sands is the primary investigator for this trial, and a paid consultant for Ventyx Biosciences, Inc. with stock and stock options in the company.
  • ET to discuss the results from the Phase 2 trial of VTX002 in patients with moderate-to-severely active UC.

Johnny Rockets and STARRY® Team up with the U.S. Space & Rocket Center to Launch a Galactic Sweepstakes to Celebrate World Space Week

Retrieved on: 
Thursday, October 5, 2023
Johnny Rockets, Moon, Internet access, Partnership, PepsiCo, UC, Rocket, Lettuce, Love, Marketing, Cheese, Science, World Space Week, Astronaut, Saturn, FAT, Amusement park, Space Camp

LOS ANGELES, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Calling all aspiring astronauts and interstellar enthusiasts! Space Week is blasting off with a partnership from Johnny Rockets, the timeless, all-American burger brand, and STARRY®, the crisp, clear, refreshing, lemon-lime flavored soda from PepsiCo. From Oct. 4 through Oct. 10, Johnny Rockets and STARRY are offering guests the opportunity to win a visit to the U.S. Space and Rocket Center®’s Space Camp® for a family of four, ages 7 and older, and enjoy a cosmically delicious World Space Week Meal at participating locations.

Key Points: 
  • Space Week is blasting off with a partnership from Johnny Rockets , the timeless, all-American burger brand, and STARRY®, the crisp, clear, refreshing, lemon-lime flavored soda from PepsiCo.
  • For more than three decades, Space Camp has ignited the imaginations of young explorers, fostering a passion for the science of space travel.
  • Five additional lucky winners will win $500 Johnny Rockets digital gift cards to enjoy burgers, shakes, fries, and fun at their local Johnny Rockets location.
  • We’re thrilled to invite guests to join us in celebrating the wonders of the galaxy during World Space Week.”
    To enter the Johnny Rockets and STARRY World Space Week sweepstakes, please visit bit.ly/JRWorldSpaceWeek .

LPL Financial Welcomes Bradford Capital Group

Retrieved on: 
Thursday, October 5, 2023
UC, LPL, RIA, Bradford, BCG, Growth, Partnership for a Secure America, University of California, Davis, Advisor Group, Business development, HNW, Financial adviser, Management

CHARLOTTE, N.C., Oct. 05, 2023 (GLOBE NEWSWIRE) -- LPL Financial LLC announced today that financial advisors and partners Chris Bradford, CFP®, Dave Meagher and Stina Bradford have joined LPL Financial’s broker-dealer, RIA and custodial platforms.

Key Points: 
  • CHARLOTTE, N.C., Oct. 05, 2023 (GLOBE NEWSWIRE) -- LPL Financial LLC announced today that financial advisors and partners Chris Bradford, CFP®, Dave Meagher and Stina Bradford have joined LPL Financial’s broker-dealer, RIA and custodial platforms.
  • Based in Sacramento, Calif., Bradford Capital Group (BCG) was founded by Managing Partner Chris Bradford, who transitioned from a career as a fulltime college football coach at UC Davis to the financial services industry in 2002.
  • “We are a dedicated team of qualified financial professionals whose main focus is to act in our clients’ best interests,” Chris Bradford said.
  • We look forward to supporting Bradford Capital Group for years to come.”